Skip to main content

Table 2 Subgroup analyses (per 100 mg/day increase)

From: Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies

 

N

RR (95% CI)

I2 (%)

P value

Total cardiovascular disease

 Sex

  Male

3

0.98 (0.89–1.08)

0.0

0.959

  Female

4

0.94 (0.73–1.13)

79.9

 Case

  Mortality

8

0.93 (0.82–1.05)

63.9

0.255

  Incidence

3

1.10 (0.82–1.48)

82.7

 Location

  United States

3

1.07 (0.78–1.48)

86.2

0.606

  Europe

2

0.93 (0.81–1.05)

0.0

  Asia

5

0.99 (0.83–1.17)

70.8

Coronary heart disease

 Sex

  Male

3

0.89 (0.81–0.99)

3.5

0.409

  Female

4

0.95 (0.83–1.09)

51.8

Case

  Mortality

5

0.81 (0.69–0.95)

36.3

0.105

  Incidence

3

0.97 (0.90–1.05)

12.7

 Location

  United States

3

0.95 (0.88–1.03)

27.6

0.439

  Asia

4

0.84 (0.68–1.03)

42

Stroke

 Subtype

  Ischemic

10

0.93 (0.88–0.98)

28.9

0.285

  Hemorrhagic

9

0.97 (0.88–1.07)

29.0

 Sex

  Male

8

0.93 (0.89–0.98)

0.9

0.884

  Female

7

0.94 (0.87–1.02)

37.2

 Case

  Mortality

4

1.07 (0.90–1.28)

45.0

0.028

  Incidence

13

0.92 (0.89–0.95)

0.0

 Location

  United states

6

0.91 (0.87–0.95)

0.0

0.140

  Europe

6

0.93 (0.89–0.98)

0.0

  Asia

5

1.00 (0.80–1.23)

63.5

Type 2 diabetes

 Sex

  Male

5

0.85 (0.79–0.93)

48.3

0.381

  Female

9

0.81 (0.75–0.87)

65.8

 Location

  United States

11

0.81 (0.77–0.86)

63.2

0.968

  Asia

9

0.79 (0.69–0.90)

62.4

All-cause mortality

 Sex

  Male

2

0.91 (0.84–0.98)

0.0

0.745

  Female

3

0.88 (0.68–1.14)

62.5

 Location

  United States

2

0.77 (0.58–1.04)

46.9

0.134

  Europe

2

0.83 (0.66–1.06)

72.6

  Asia

3

0.98 (0.87–1.11)

51.5

  1. RR relative risk, 95% CI 95 confidence interval (lower limit–upper limit)